Diabetic Wound Healing in Cuba for Illinois Families

Diabetic wound healing is fundamentally different from normal wound healing. High blood sugar impairs immune function, reduces circulation, damages nerves (leading to unrecognized pressure and trauma), and disrupts the normal inflammatory and proliferative phases of wound healing. As a result, diabetic wounds often become chronic — stuck in a state of inflammation without progressing to healing.

Cuba's diabetic wound healing program addresses all of these factors simultaneously. Heberprot-P (recombinant human epidermal growth factor) is injected directly into the wound bed to stimulate the proliferative phase of healing — cell growth, angiogenesis (new blood vessel formation), and granulation tissue formation. This is combined with surgical debridement (to remove barriers to healing), infection management (to eliminate bacteria that perpetuate inflammation), off-loading (to eliminate pressure that damages new tissue), vascular assessment (to ensure adequate blood flow), and metabolic management (to optimize blood sugar and nutrition for healing).

The program is delivered as an intensive 2–4 week inpatient or outpatient program, with daily treatment and monitoring. The concentrated, coordinated approach — with all treatments delivered by a single multidisciplinary team — is key to success. For American patients with chronic diabetic wounds that have not healed with standard U.S. care, Cuba's comprehensive wound healing program offers an additional treatment option. Individual outcomes vary based on wound severity, vascular status, infection control, and overall health.